Source / episode info

• **Episode:**397
• **Title:**Divine Intervention Episode 397 – Pulmonary Pathophysiology Series 3
• **Published:**2022-06-23
• Source:Episode page

One-liner

This episode provides a comprehensive review of asthma and COPD pathophysiology (Type I hypersensitivity), the pharmacological management ladders for both conditions, acute hyperkalemia treatment protocols, and the critical side effects and uses of systemic and inhaled corticosteroids.

High-yield summary

• Asthma Pathophysiology: A Type 1 hypersensitivity reaction triggered by airway antigens -> IgE class switching (via IL-4) -> IgE binds to Fc- receptors on mast cells -> Cross-linking triggers degranulation, releasing mediators (histamines, leukotrienes, prostaglandins) and eosinophil chemoattractants.
• Asthma vs. COPD Management Ladder: The treatment sequence differs: Asthma (Short _2 -> ICS -> LABA/LAMA -> OCS); COPD (Short _2 -> LAMA/LABA -> ICS -> OCS).
• Acute Hyperkalemia Management: Always prioritize cardiac membrane stabilization first using Calcium Gluconate or Calcium Chloride. Subsequent steps involve shifting K+ intracellularly (Insulin + Glucose, Beta-agonists) and finally removing it (Kayexalate, dialysis).
• Corticosteroid Mechanism: Steroids are lipid-soluble; they act at the genetic level by binding to DNA response elements and inhibiting inflammatory gene transcription (e.g., preventing leukotriene/histamine synthesis via inhibition of NF-B).
• Steroid Side Effect Pearls: Long-term use causes: 1) GI upset -> PUD (PPI prophylaxis); 2) Skin infections -> Oral candidiasis (Nystatin); 3) Bone loss -> Osteoporosis (Bisphosphonates); 4) HPA axis suppression -> Adrenal crisis risk.
• Acute Crisis Management: In an acute exacerbation, IV corticosteroids are required for both asthma and COPD; in the ICU setting, steroids may be needed to maintain the permissive effect on the sympathetic nervous system (SNS).

Learning objectives

• Describe the pathophysiology of asthma as a Type 1 hypersensitivity reaction involving IgE and mast cell degranulation.
• Differentiate the pharmacological management "ladders" for acute exacerbations in Asthma versus COPD.
• Outline the sequential, life-saving steps for managing severe hyperkalemia, prioritizing cardiac stabilization.
• Identify the key side effects of chronic corticosteroid use (GI, bone, endocrine) and their respective prophylactic treatments.
• Understand the mechanism by which inhaled corticosteroids reduce inflammation at the genetic level (NF-\kappaB inhibition).